These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost. Alt E; Haehnel I; Beilharz C; Prietzel K; Preter D; Stemberger A; Fliedner T; Erhardt W; Schömig A Circulation; 2000 Mar; 101(12):1453-8. PubMed ID: 10736292 [TBL] [Abstract][Full Text] [Related]
3. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Herrmann R; Schmidmaier G; Märkl B; Resch A; Hähnel I; Stemberger A; Alt E Thromb Haemost; 1999 Jul; 82(1):51-7. PubMed ID: 10456454 [TBL] [Abstract][Full Text] [Related]
4. Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound. Voisard R; Stemberger A; Baur R; Herter T; Hähnel I; Resch A; Seliger C; Hemmer W; Hannekum A; Hombach V; Alt E Int J Cardiol; 2005 Jul; 102(3):425-33. PubMed ID: 16004887 [TBL] [Abstract][Full Text] [Related]
5. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis. Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493 [TBL] [Abstract][Full Text] [Related]
6. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751 [TBL] [Abstract][Full Text] [Related]
7. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. Yamawaki T; Shimokawa H; Kozai T; Miyata K; Higo T; Tanaka E; Egashira K; Shiraishi T; Tamai H; Igaki K; Takeshita A J Am Coll Cardiol; 1998 Sep; 32(3):780-6. PubMed ID: 9741527 [TBL] [Abstract][Full Text] [Related]
8. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty. Unterberg C; Sandrock D; Nebendahl K; Buchwald AB J Am Coll Cardiol; 1995 Dec; 26(7):1747-54. PubMed ID: 7594113 [TBL] [Abstract][Full Text] [Related]
9. Modeling of degradation and drug release from a biodegradable stent coating. Prabhu S; Hossainy S J Biomed Mater Res A; 2007 Mar; 80(3):732-41. PubMed ID: 17167794 [TBL] [Abstract][Full Text] [Related]
10. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model. Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137 [TBL] [Abstract][Full Text] [Related]
11. Thrombin inhibition and intracoronary thrombus formation: effect of polyethylene glycol-coupled hirudin in the stenosed, locally injured canine coronary artery. Rübsamen K; Kirchengast M Coron Artery Dis; 1998; 9(1):35-42. PubMed ID: 9589189 [TBL] [Abstract][Full Text] [Related]
12. Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices. Lahann J; Klee D; Pluester W; Hoecker H Biomaterials; 2001 Apr; 22(8):817-26. PubMed ID: 11246950 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo performance of a dual drug-eluting stent (DDES). Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244 [TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of anti-platelet and anti-inflammation of drug-coated Co-Cr substrates for prevention of initial in-stent restenosis. Lih E; Jung JW; Joung YK; Ahn DJ; Han DK Colloids Surf B Biointerfaces; 2016 Apr; 140():353-360. PubMed ID: 26774572 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of neointimal proliferation after coronary angioplasty by low-molecular-weight heparin (clivarine) and polyethyleneglycol-hirudin. Buchwald AB; Hammerschmidt S; Stevens J; Göring J; Nebendahl K; Unterberg C J Cardiovasc Pharmacol; 1996 Oct; 28(4):481-7. PubMed ID: 8891870 [TBL] [Abstract][Full Text] [Related]
17. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting. Muller DW; Gordon D; Topol EJ; Levy RJ; Golomb G Am Heart J; 1996 Feb; 131(2):211-8. PubMed ID: 8579010 [TBL] [Abstract][Full Text] [Related]
18. Antiproliferative stent coatings: Taxol and related compounds. Herdeg C; Oberhoff M; Karsch KR Semin Interv Cardiol; 1998; 3(3-4):197-9. PubMed ID: 10406693 [TBL] [Abstract][Full Text] [Related]